I guess Pfizer just made the best offer. Without them, BioNTech might have partnered with some other pharma corp: Merck (the German company, not the US wartime

I guess Pfizer just made the best offer. Without them, BioNTech might have partnered with some other pharma corp: Merck (the German company, not the US wartime spinoff) is headquartered 30 km from BioNTech, Sanofi has facilities 20km away and there are a few more around the block that have significant experience in both navigating regulatory frameworks and ramping up production. In such a scenario, maybe they wouldn't provide 60% of EU shipments now (the numbers I have at hands), but "produced nothing" seems to lowball it.